Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol. 1997, 15 (1): 277-284.
CAS
PubMed
Google Scholar
Herskovic A, Martz K, al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992, 326 (24): 1593-1598.
Article
CAS
PubMed
Google Scholar
Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, et al: Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999, 281 (17): 1623-1627. 10.1001/jama.281.17.1623.
Article
CAS
PubMed
Google Scholar
Kleinberg L, Forastiere AA: Chemoradiation in the management of esophageal cancer. J Clin Oncol. 2007, 25 (26): 4110-4117. 10.1200/JCO.2007.12.0881.
Article
CAS
PubMed
Google Scholar
Kleinberg L, Gibson MK, Forastiere AA: Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization. Nat Clin Pract Oncol. 2007, 4 (5): 282-294. 10.1038/ncponc0796.
Article
CAS
PubMed
Google Scholar
Sasaki Y, Amano T, Morita M, Shinkai T, Eguchi K, Tamura T, Ohe Y, Kojima A, Saijo N: Phase I study and pharmacological analysis of cis-diammine (glycolato) platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion. Cancer Res. 1991, 51 (5): 1472-1477.
CAS
PubMed
Google Scholar
Uchida N, Takeda Y, Hojo K, Maekawa R, Sugita K, Yoshioka T: Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model. Eur J Cancer. 1998, 34 (11): 1796-1801. 10.1016/S0959-8049(98)00194-4.
Article
CAS
PubMed
Google Scholar
Kameyama Y, Okazaki N, Nakagawa M, Koshida H, Nakamura M, Gemba M: Nephrotoxicity of a new platinum compound, 254-S, evaluated with rat kidney cortical slices. Toxicol Lett. 1990, 52 (1): 15-24. 10.1016/0378-4274(90)90161-E.
Article
CAS
PubMed
Google Scholar
Grunberger B, Raderer M, Schmidinger M, Hejna M: Palliative chemotherapy for recurrent and metastatic esophageal cancer. Anticancer Res. 2007, 27 (4C): 2705-2714.
PubMed
Google Scholar
Muro K, Hamaguchi T, Ohtsu A, Boku N, Chin K, Hyodo I, Fujita H, Takiyama W, Ohtsu T: A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol. 2004, 15 (6): 955-959. 10.1093/annonc/mdh231.
Article
CAS
PubMed
Google Scholar
Taguchi T, Wakui A, Nabeya K, Kurihara M, Isono K, Kakegawa T, Ota K: [A phase II clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group]. Gan To Kagaku Ryoho. 1992, 19 (4): 483-488.
CAS
PubMed
Google Scholar
Sato Y, Takayama T, Sagawa T, Okamoto T, Miyanishi K, Sato T, Araki H, Iyama S, Abe S, Murase K, et al: A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer. Cancer Chemother Pharmacol. 2006, 58 (5): 570-576. 10.1007/s00280-006-0193-x.
Article
CAS
PubMed
Google Scholar
Kodaira T, Fuwa N, Kamata M, Furutani K, Tachibana H, Yamazaki T: Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma. Anticancer Res. 2006, 26 (1B): 471-478.
CAS
PubMed
Google Scholar
Ishikura S, Ohtsu A, Shirao K, Muro K, Kagami Y, Nihei K, Mera K, Ito Y, Boku N, Yoshida S: A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with T4 esophageal cancer: Japan Clinical Oncology Group trial (JCOG 9908). Esophagus. 2005, 2: 133-137. 10.1007/s10388-005-0055-3.
Article
Google Scholar
O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA: Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994, 331 (8): 502-507. 10.1056/NEJM199408253310803.
Article
PubMed
Google Scholar
Lawrence TS, Tepper JE, Blackstock AW: Fluoropyrimidine-Radiation Interactions in Cells and Tumors. Semin Radiat Oncol. 1997, 7 (4): 260-266. 10.1016/S1053-4296(97)80024-0.
Article
PubMed
Google Scholar
Begg AC: Cisplatin and radiation: interaction probabilities and therapeutic possibilities. Int J Radiat Oncol Biol Phys. 1990, 19 (5): 1183-1189.
Article
CAS
PubMed
Google Scholar
Yang LX, Douple EB, O'Hara JA, Wang HJ: Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks. Radiat Res. 1995, 143 (3): 302-308. 10.2307/3579217.
Article
CAS
PubMed
Google Scholar
Cividalli A, Ceciarelli F, Livdi E, Altavista P, Cruciani G, Marchetti P, Danesi DT: Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys. 2002, 52 (4): 1092-1098.
Article
CAS
PubMed
Google Scholar
Tahara M, Ohtsu A, Hironaka S, Boku N, Ishikura S, Miyata Y, Ogino T, Yoshida S: Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer. Jpn J Clin Oncol. 2005, 35 (6): 316-323. 10.1093/jjco/hyi095.
Article
PubMed
Google Scholar
Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, et al: Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol. 1999, 17 (9): 2915-2921.
CAS
PubMed
Google Scholar
Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP: INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002, 20 (5): 1167-1174. 10.1200/JCO.20.5.1167.
Article
CAS
PubMed
Google Scholar
Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, et al: Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys. 2003, 57 (2): 425-433. 10.1016/S0360-3016(03)00585-6.
Article
PubMed
Google Scholar
Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M: Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516). Jpn J Clin Oncol. 2004, 34 (10): 615-619. 10.1093/jjco/hyh107.
Article
PubMed
Google Scholar
Rich TA, Ajani JA, Morrison WH, Ota D, Levin B: Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother Oncol. 1993, 27 (3): 209-215. 10.1016/0167-8140(93)90076-K.
Article
CAS
PubMed
Google Scholar
Schaake-Koning C, Bogaert van den W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med. 1992, 326 (8): 524-530.
Article
CAS
PubMed
Google Scholar
Itoh Y, Fuwa N: Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer. Radiat Med. 2006, 24 (4): 277-281. 10.1007/s11604-005-1517-1.
Article
PubMed
Google Scholar
Sasamoto R, Sakai K, Inakoshi H, Sueyama H, Saito M, Sugita T, Tsuchida E, Ito T, Matsumoto Y, Yamanoi T, et al: Long-term results of chemoradiotherapy for locally advanced esophageal cancer, using daily low-dose 5-fluorouracil and cis-diammine-dichloro-platinum (CDDP). Int J Clin Oncol. 2007, 12 (1): 25-30. 10.1007/s10147-006-0617-y.
Article
CAS
PubMed
Google Scholar
Sai H, Mitsumori M, Yamauchi C, Araki N, Okumura S, Nagata Y, Nishimura Y, Hiraoka M: Concurrent chemoradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil. Int J Clin Oncol. 2004, 9 (3): 149-153. 10.1007/s10147-004-0385-5.
Article
CAS
PubMed
Google Scholar
Nishimura Y, Mitsumori M, Hiraoka M, Koike R, Nakamatsu K, Kawamura M, Negoro Y, Fujiwara K, Sakurai H, Mitsuhashi N: A randomized phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer: Short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021). Radiother Oncol. 2009, 92 (2): 260-265. 10.1016/j.radonc.2008.12.012.
Article
CAS
PubMed
Google Scholar
Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J: Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007, 8 (3): 226-234. 10.1016/S1470-2045(07)70039-6.
Article
CAS
PubMed
Google Scholar
Mariette C, Piessen G, Triboulet JP: Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol. 2007, 8 (6): 545-553. 10.1016/S1470-2045(07)70172-9.
Article
PubMed
Google Scholar
Avery KN, Metcalfe C, Barham CP, Alderson D, Falk SJ, Blazeby JM: Quality of life during potentially curative treatment for locally advanced oesophageal cancer. Br J Surg. 2007, 94 (11): 1369-1376. 10.1002/bjs.5888.
Article
CAS
PubMed
Google Scholar
Lagergren P, Avery KN, Hughes R, Barham CP, Alderson D, Falk SJ, Blazeby JM: Health-related quality of life among patients cured by surgery for esophageal cancer. Cancer. 2007, 110 (3): 686-693. 10.1002/cncr.22833.
Article
PubMed
Google Scholar
Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T, Yoshida S: Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003, 21 (14): 2697-2702. 10.1200/JCO.2003.03.055.
Article
CAS
PubMed
Google Scholar
Kumekawa Y, Kaneko K, Ito H, Kurahashi T, Konishi K, Katagiri A, Yamamoto T, Kuwahara M, Kubota Y, Muramoto T, et al: Late toxicity in complete response cases after definitive chemoradiotherapy for esophageal squamous cell carcinoma. J Gastroenterol. 2006, 41 (5): 425-432. 10.1007/s00535-006-1771-8.
Article
CAS
PubMed
Google Scholar
Inaba H, Tsuda T, Miyazaki A, Watanabe Y, Nakaya S, Koitabashi Y, Ogihara K, Hara T, Kato N, Kobayashi Y, et al: [Clinical study of the combination of small amount of nedaplatin (CDGP)/5-FU with radiation for the treatment of esophageal cancer]. Nippon Shokakibyo Gakkai Zasshi. 2002, 99 (10): 1191-1196.
PubMed
Google Scholar
Kato H, Fukuchi M, Manda R, Nakajima M, Miyazaki T, Sohda M, Masuda N, Fukai Y, Tsukada K, Kuwano H: Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas. Anticancer Res. 2003, 23 (4): 3493-3498.
CAS
PubMed
Google Scholar
Yamanaka H, Motohiro T, Michiura T, Asai A, Mori T, Hioki K: Nedaplatin and 5-FU combined with radiation in the treatment for esophageal cancer. Jpn J Thorac Cardiovasc Surg. 1998, 46 (10): 943-948.
Article
CAS
PubMed
Google Scholar
Nemoto K, Matsushita H, Ogawa Y, Takeda K, Takahashi C, Britton KR, Takai Y, Miyazaki S, Miyata T, Yamada S: Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer. Am J Clin Oncol. 2003, 26 (1): 46-49. 10.1097/00000421-200302000-00010.
Article
CAS
PubMed
Google Scholar
Yamashita H, Nakagawa K, Tago M, Igaki H, Nakamura N, Shiraishi K, Sasano N, Ohtomo K: Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study. Dis Esophagus. 2006, 19 (1): 15-19. 10.1111/j.1442-2050.2006.00531.x.
Article
CAS
PubMed
Google Scholar
Jingu K, Nemoto K, Matsushita H, Takahashi C, Ogawa Y, Sugawara T, Nakata E, Takai Y, Yamada S: Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer. 2006, 6: 50-10.1186/1471-2407-6-50.
Article
PubMed
PubMed Central
Google Scholar